A, S., MA, N., R, A., AA, K., HS, D., A, S., . . . D, D. (2026). Discovery, preclinical safety, and efficacy characterization of SMAC mimetic S-016-1348 as a potential cancer therapeutic. Molecular therapy : the journal of the American Society of Gene Therapy, 34(4), 2408. https://doi.org/10.1016/j.ymthe.2025.12.056
Chicago Style (17th ed.) CitationA, Sinha, et al. "Discovery, Preclinical Safety, and Efficacy Characterization of SMAC Mimetic S-016-1348 as a Potential Cancer Therapeutic." Molecular Therapy : The Journal of the American Society of Gene Therapy 34, no. 4 (2026): 2408. https://doi.org/10.1016/j.ymthe.2025.12.056.
MLA (9th ed.) CitationA, Sinha, et al. "Discovery, Preclinical Safety, and Efficacy Characterization of SMAC Mimetic S-016-1348 as a Potential Cancer Therapeutic." Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 34, no. 4, 2026, p. 2408, https://doi.org/10.1016/j.ymthe.2025.12.056.